CAS NO: | 1646499-97-9 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | ML382 is a potent and selectiveMRGPRX1(Mas-related G protein-coupled receptor X1, MrgX1) positive allosteric modulator, with anEC50of 190 nM[1]. | ||||||||||||||||
IC50& Target | EC50: 190 nM (MRGPRX1)[1] | ||||||||||||||||
体外研究 (In Vitro) | In the absence of ML382, the IC50for BAM8-22 inhibition ofICais 0.66 ± 0.05 μM. In the presence of 0.1 μM, 1 μM, 10 μM, and 30 μM ML382, BAM8-22 IC50is reduced to 0.43 ± 0.02 μM, 0.25 ± 0.02 μM, 0.06 ± 0.01 μM, and 0.08 ± 0.01 μM, respectively. A lower IC50generally indicates a higher potency; thus, ML382 dose-dependently increases the potency of BAM8–22, further demonstrating that ML382 is a positive allosteric modulator of MRGPRX1[1]. | ||||||||||||||||
体内研究 (In Vivo) | ML382 (5 μM) significantly increases inhibition ofICaby a low concentration of BAM8–22 (0.5 μM) in DRG neurons fromMrgprX1mice. ML382 enhances the inhibition of spinal synaptic transmission by BAM8-22 inMrgprX1mice. ML382 (25 μM, 125 μM, and 250 μM; 5 μL; i.th.;) dose-dependently attenuates heat hypersensitivity inMrgprX1mice. ML382 (lumbar puncture injection; 25 μM, 5 μL) leads to a significant increase in postconditioning time spent in the ML382-paired chamber, compared with the preconditioning value. ML382 inhibits nerve injury-induced ongoing pain inMrgprX1mice[1]. | ||||||||||||||||
分子量 | 360.43 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C18H20N2O4S | ||||||||||||||||
CAS 号 | 1646499-97-9 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(277.45 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|